Ignite Creation Date:
2025-12-24 @ 6:58 PM
Ignite Modification Date:
2026-01-04 @ 12:01 AM
Study NCT ID:
NCT02965157
Status:
UNKNOWN
Last Update Posted:
2016-11-16
First Post:
2016-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Study of Anti-CD20-CAR-engineered T Cells in Patients With Chemotherapy Resistant or Refractory CD20+ Lymphoma
Sponsor:
Beijing Biohealthcare Biotechnology Co.,Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08
Start Date Type:
None
Primary Completion Date:
2018-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2016-08-31
First Submit QC Date:
None
Study First Post Date:
2016-11-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-14
Last Update Post Date:
2016-11-16
Last Update Post Date Type:
ESTIMATED